Virtu Financial LLC - IMMUNOCELLULAR THERAPEUTICS ownership

Back to all holdings Add to watchlist

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 17 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Virtu Financial LLC ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$15,000
-53.1%
71,027
-42.8%
0.00%0.0%
Q2 2018$32,000
-44.8%
124,195
-46.4%
0.00%
-66.7%
Q1 2018$58,000
-4.9%
231,736
+19.8%
0.00%0.0%
Q4 2017$61,000
+408.3%
193,493
+516.5%
0.00%
+200.0%
Q3 2017$12,000–31,387–0.00%–
 Download
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q4 2017.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders